Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterol Hepatol

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    June 2017
  1. DOMENECH E, Lopez-Sanroman A, Nos P, Vera M, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the monitoring, prevention and treatment of post-operative recurrence in Crohn's disease.
    Gastroenterol Hepatol. 2017 Jun 9. pii: S0210-5705(17)30126.
    PubMed     Text format     Abstract available


    December 2016
  2. MONTESERIN L, Jimenez M, Molina G, Reyes N, et al
    Colonic pseudopolyposis in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016 Dec 21. pii: S0210-5705(16)30161.
    PubMed     Text format    


    September 2016
  3. GARCIA-LOPEZ S
    Inflammatory bowel disease in Digestive Disease Week 2016: advances in epidemiology, follow-up, treatment monitoring, optimisation and individual tailoring, and colon cancer prevention.
    Gastroenterol Hepatol. 2016;39 Suppl 1:29-35.
    PubMed     Text format     Abstract available


  4. CHAPARRO M
    Treatment of inflammatory bowel disease: what's new in Digestive Disease Week 2016.
    Gastroenterol Hepatol. 2016;39 Suppl 1:20-28.
    PubMed     Text format     Abstract available


  5. GOMOLLON F
    Treatment adherence is always worse than we think: an unresolved problem in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016;39 Suppl 1:14-19.
    PubMed     Text format     Abstract available


    May 2016
  6. LOZOYA ANGULO ME, de Las Heras Gomez I, Martinez Villanueva M, Noguera Velasco JA, et al
    [Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders].
    Gastroenterol Hepatol. 2016 May 31. pii: S0210-5705(16)30048.
    PubMed     Text format     Abstract available


  7. COLLAZO DIEGUEZ M, Gonzalez Carrera V
    [Foot drop during adalimumab therapy for Crohn disease].
    Gastroenterol Hepatol. 2016 May 13. pii: S0210-5705(16)30042.
    PubMed     Text format    


    March 2016
  8. MIRANDA-GARCIA P, Chaparro M, Gisbert JP
    Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2016 Mar 25. pii: S0210-5705(16)30001.
    PubMed     Text format     Abstract available


  9. GINARD D, Khorrami S, Perez-Carazo L, Tavio-Hernandez E, et al
    [Efficacy and effectiveness of biologic therapy in inflammatory bowel disease. EFIFECT study].
    Gastroenterol Hepatol. 2016 Mar 18. pii: S0210-5705(16)00090.
    PubMed     Text format     Abstract available


  10. IRIARTE A, Zaera C, Bachiller-Corral J, Lopez-Sanroman A, et al
    [Inflammatory bowel disease as a paradoxical effect of anti-TNF alpha therapy].
    Gastroenterol Hepatol. 2016 Mar 15. pii: S0210-5705(16)00088.
    PubMed     Text format     Abstract available


  11. BATISTA L, Zabana Y, Aceituno M, Esteve M, et al
    Men in the spotlight: A rare case of penile squamous carcinoma associated with human papillomavirus (HPV) infection in a patient with ulcerative colitis (UC).
    Gastroenterol Hepatol. 2016 Mar 3. pii: S0210-5705(16)00037.
    PubMed     Text format    


    February 2016
  12. DOMENECH E, Gisbert JP
    [Efficacy and safety of vedolizumab in the treatment of ulcerative colitis].
    Gastroenterol Hepatol. 2016 Feb 29. pii: S0210-5705(16)00025.
    PubMed     Text format     Abstract available


  13. MUNOZ VILLAFRANCA C, Bravo Rodriguez MT, Ortiz de Zarate J, Arreba Gonzalez P, et al
    [Clinical outcome after discontinuation of infliximab in patients with ulcerative colitis in deep remission].
    Gastroenterol Hepatol. 2016 Feb 29. pii: S0210-5705(16)00026.
    PubMed     Text format     Abstract available


    January 2016
  14. AMO L, Gonzalez-Lama Y, Suarez C, Blazquez I, et al
    [Impact of the incorporation of a nurse in an inflammatory bowel disease unit].
    Gastroenterol Hepatol. 2016 Jan 27. pii: S0210-5705(15)00227.
    PubMed     Text format     Abstract available


    November 2015
  15. CHAPARRO M, Gisbert JP
    [New molecules in the treatment of inflammatory bowel disease].
    Gastroenterol Hepatol. 2015 Nov 26. pii: S0210-5705(15)00244.
    PubMed     Text format     Abstract available


  16. RUIZ-CUESTA P, Gonzalez-Alayon C, Jurado-Garcia J, Iglesias-Flores EM, et al
    Adherence to a predefined vaccination program in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2015 Nov 18. pii: S0210-5705(15)00240.
    PubMed     Text format     Abstract available


  17. LOPEZ-IBANEZ M, Marin-Jimenez I
    [Drugs and anti-drug antibody levels in the management of patients with inflammatory bowel disease].
    Gastroenterol Hepatol. 2015 Nov 18. pii: S0210-5705(15)00236.
    PubMed     Text format    


    September 2015
  18. GARCIA-LOPEZ S
    [Epidemiology, follow-up, monitoring and other aspects of inflammatory bowel disease].
    Gastroenterol Hepatol. 2015;38 Suppl 1:32-8.
    PubMed     Text format     Abstract available


  19. CHAPARRO M
    [Natural history, complications, safety and pregnancy in inflammatory bowel disease].
    Gastroenterol Hepatol. 2015;38 Suppl 1:20-31.
    PubMed     Text format     Abstract available


    August 2015
  20. TINOCO R, Garcia E, Ramirez F, Correro F, et al
    [A case of de novo inflammatory bowel disease after liver transplantation for cryptogenic cirrhosis].
    Gastroenterol Hepatol. 2015 Aug 25. pii: S0210-5705(15)00167.
    PubMed     Text format    


  21. SENOSIAIN C, Gonzalez-Tallon A A, Lopez-Sanroman A, Mateos ML, et al
    Hepatitis E seroprevalence in inflammatory bowel disease.
    Gastroenterol Hepatol. 2015 Aug 6. pii: S0210-5705(15)00148.
    PubMed     Text format     Abstract available


    July 2015
  22. ALDEGUER X, Sicras-Mainar A
    Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: A database study.
    Gastroenterol Hepatol. 2015 Jul 23. pii: S0210-5705(15)00110.
    PubMed     Text format     Abstract available


    June 2015
  23. GISBERT JP, Gomollon F, Mendez I
    [Cost-effectiveness assessment through theoretical cost-minimization analysis of the use of two gastro-resistant modified-release mesalazine formulations in the management of ulcerative colitis in Spain].
    Gastroenterol Hepatol. 2015 Jun 10. pii: S0210-5705(15)00117.
    PubMed     Text format     Abstract available


    May 2015
  24. MARIN-JIMENEZ I, Gisbert JP, Perez-Calle JL, Garcia-Sanchez V, et al
    [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
    Gastroenterol Hepatol. 2015 May 13. pii: S0210-5705(15)00101.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: